Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Rezzayo 200 mg powder for concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
rezafungin acetate
Company:  
Napp Pharmaceuticals Limited See contact details
ATC code: 
J02AX08
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 31 Jan 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Napp Pharmaceuticals Limited
Company image
Address
Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0GW
WWW
http://www.napp.co.uk
Telephone
+44 (0)1223 424 444
Medical Information e-mail
[email protected]